Women's Health Medicine
Volume 2, Issue 5 , Pages 6-12, September 2005

Progestogen-only contraception

Diana Mansour is a Consultant in Community Gynaecology and Reproductive Healthcare and Head of Service for Contraception and Sexual Health for Newcastle Primary Care Trust. In addition, she serves as an Honorary Lecturer at the University of Newcastle and is Deputy Medical Director of the local Primary Care Trust. She qualified from the Welsh School of Medicine in Cardiff and in 1995 became the first RCOG-accredited Community Gynaecologist.

Abstract 

Over the last 40 years there have been enormous advances in the field of contraception. In the late 1950s, options were restricted to male and female sterilization, condoms and diaphragms/cervical caps. Now in the early part of the 21st century, men and women have over 13 methods to choose from; yet few are aware of this diversity, and health professionals often give misinformation about their safety and use. Progestogen-only contraception still seems to be shrouded in mystique. Can those who are advised ‘against the pill’ use progestogen-only pills (POPs)? Will fertility be affected by the injectable and what about long-term side-effects of implants – are they known? In fact, the most recent advances have resulted in the development of POPs that are now as effective as combined pills. Research has identified those who can safely use injectables and that their action is reversible although some delay (up to a year) is to be expected. Contraceptive implants are reversible and provide almost 100% effective contraception. The progestogen-only intrauterine system is now changing the face of gynaecology, with numbers of women seeking sterilization and hysterectomy falling.

Keywords:  contraception , contraceptive implant , etonorgestrel , intrauterine system , progestogen

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1744-1870(06)00080-1

doi:10.1383/wohm.2005.2.5.6

Women's Health Medicine
Volume 2, Issue 5 , Pages 6-12, September 2005

Article Tools